COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test
Objectives: Observing the serological cross-reactivity between SARS-CoV-2 and dengue virus (DV), we aimed to elucidate its effect on dengue serodiagnosis and infectivity in a highly dengue-endemic city in India. Methods: A total of 52 COVID-19 (reverse transcription-polymerase chain reaction [RT-PCR...
Main Authors: | Himadri Nath, Abinash Mallick, Subrata Roy, Tathagata Kayal, Sumit Ranjan, Susanta Sengupta, Soumi Sukla, Subhajit Biswas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971222004088 |
Similar Items
-
Serological evidence of Zika virus circulation with dengue and chikungunya infections in Sri Lanka from 2017
by: Harshi Abeygoonawardena, et al.
Published: (2023-01-01) -
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
by: Wang-Da Liu, et al.
Published: (2021-12-01) -
Spreading of dengue virus infection cases in Malda district of West Bengal, India during COVID-19 pandemic situation (2020 to 2022): A cross-sectional study
by: Puranjay Saha, et al.
Published: (2024-12-01) -
Development of Immunoassay Based on Monoclonal Antibody Reacted with the Neonicotinoid Insecticides Clothianidin and Dinotefuran
by: Seiji Iwasa, et al.
Published: (2012-11-01) -
First Outbreak of Dengue in Jorhat District of Assam
by: Pallabi Sargiary, et al.
Published: (2018-04-01)